Probability and ranges of a medication adverse event.a, b

Relative risk of adverse events in randomized controlled trials with bee venom therapy and saline.

Jeong Hwan Park (742550)
Bo Kyung Yim (742551)
Jun-Hwan Lee (742552)
Sanghun Lee (742553)
Tae-Hun Kim (62458)

May 2015

Relative risk of adverse events in randomized controlled trials with bee venom therapy and saline...

Risk patterns in drug safety study using relative times by accelerated failure time models when proportional hazards assumption is questionable : An illustrative case study of cancer risk of patients on glucose-lowering therapies

Ng, Edmond S W
Klungel, Olaf H.
Groenwold, Rolf H H
Van Staa, Tjeerd Pieter

September 2015

Observational drug safety studies may be susceptible to confounding or protopathic bias. This bias m...

Comparison of the rates of antibiotic changes after each testA.

Kayoko Hayakawa (420483)
Kazuhisa Mezaki (547392)
Masao Kobayakawa (775279)
Kei Yamamoto (4170022)
Yoshikazu Mutoh (4268503)
Motoyuki Tsuboi (4268506)
Takehiro Hasimoto (4268500)
Maki Nagamatsu (547391)
Satoshi Kutsuna (3308052)
Nozomi Takeshita (3308049)
Yuichi Katanami (4170031)
Masahiro Ishikane (580253)
Norio Ohmagari (295944)

July 2017

Comparison of the rates of antibiotic changes after each test<a href="http://www.plosone.org/arti...

Incidence of adverse drug reactions.*

Monique Wasunna (157135)
Simon Njenga (3119955)
Manica Balasegaram (156987)
Neal Alexander (18417)
Raymond Omollo (156992)
Tansy Edwards (122527)
Thomas P. C. Dorlo (321337)
Brima Musa (157009)
Mohammed Hassan Sharaf Ali (3119958)
Mohammed Yasein Elamin (3119946)
George Kirigi (157066)
Rashid Juma (463480)
Anke E. Kip (3119949)
Gerard J. Schoone (244545)
Asrat Hailu (59005)
Joseph Olobo (156982)
Sally Ellis (157129)
Robert Kimutai (157106)
Susan Wells (3119952)
Eltahir Awad Gasim Khalil (3119940)
Nathalie Strub Wourgaft (3119943)
Fabiana Alves (217602)
Ahmed Musa (156973)

September 2016

Incidence of adverse drug reactions.<a href="http://www.plosntds.org/article/info:doi/10.137...

Distribution of outcomes in case of exposure.

Laurent Coudeville (112236)
Annelies Van Rie (36715)
Denis Getsios (60905)
J. Jaime Caro (371754)
Pascal Crépey (371756)
Van Hung Nguyen (60909)

February 2013

Distribution of outcomes in case of contact with an infectious person according to immunological ...

Incidence of patient complications.

ZheFeng Quan (738491)
Ming Tian (382196)
Ping Chi (738492)
Xin Li (51274)
HaiLi He (738493)
Chao Luo (343569)

May 2015

* Values presented as n (%)<a href="http://www.plosone.org/article/info:doi/10.1371/j...

Relation between the probability of disease and the threshold probabilities for testing and treatment (adopted from [3]).

Athanasios Tsalatsanis (354144)
Iztok Hozo (68993)
Ambuj Kumar (302537)
Benjamin Djulbegovic (68992)

August 2015

Relation between the probability of disease and the threshold probabilities for testing and treat...

Adverse effects during treatmenta.

Emily K. Tarleton (4175953)
Benjamin Littenberg (65282)
Charles D. MacLean (4175950)
Amanda G. Kennedy (4175947)
Christopher Daley (1779979)

June 2017

Adverse effects during treatment<a href="http://www.plosone.org/article/info:doi/10.1371/journal....

Individual risk for ARB acquisition.

Jonatan Almagor (5215994)
Elizabeth Temkin (5215991)
Itzhak Benenson (328126)
Noga Fallach (5215988)
Yehuda Carmeli (224072)

May 2018

Probability of ARB-H and ARB-L acquisition during a 6-day hospital stay for patients treated and ...

Quantitative methods to support drug benefit-risk assessment

Caster, Ola

January 2014

Joint evaluation of drugs’ beneficial and adverse effects is required in many situations, in particu...

Odds ratio and 95% confidence intervals for the rate of hazardous prescribing at each quarter interval compared to preintervention for the composite outcomes.

Sarah Rodgers (2646067)
Amelia C. Taylor (14129688)
Stephen A. Roberts (8494242)
Thomas Allen (1342170)
Darren M. Ashcroft (7359257)
James Barrett (3861232)
Matthew J. Boyd (14129691)
Rachel A. Elliott (8569593)
Kamlesh Khunti (171607)
Aziz Sheikh (18504)
Despina Laparidou (4440106)
Aloysius Niroshan Siriwardena (7399064)
Anthony J. Avery (5900345)

November 2022

Odds ratio and 95% confidence intervals for the rate of hazardous prescribing at each quarter interv...

Summary of all treatment-related adverse events (safety population).

Chaoying Hu (713788)
Jingying Jia (713789)
Kelly Dong (713790)
Linda Luo (713791)
Kai Wu (221862)
Rashmi Mehta (713792)
Jack Peng (713793)
Yan Ren (149348)
Annette Gross (713794)
Hui Yu (27723)

March 2015

*n numbers represent the number of subjects experiencing an event, which may be different to the ...

Study on the Increased Probability of Detecting Adverse Drug Reactions Based on Bayes’ Theorem: Evaluation of the Usefulness of Information on the Onset Timing of Adverse Drug Reactions

大島, 新司
延壽寺, 恭子
根岸, 彰生
秋元, 勇人
大原, 厚祐
冲田, 光良
沼尻, 幸彦
井上, 直子
大嶋, 繁
寺尾, 哲
小林, 大介

September 2017

In order to avoid adverse drug reactions (ADRs), pharmacists are reconstructing ADR-related informat...

Number and percentages of subjects showing adverse events after administration of drugs in different treatment arms.

Shantanu Kumar Kar (704077)
Bhagirathi Dwibedi (704078)
Anna Salomi Kerketa (704079)
Antaryami Maharana (704080)
Sudanshu S Panda (704081)
Prafulla Chandra Mohanty (704082)
John Horton (218580)
Cherubala P Ramachandran (704083)

March 2015

Number and percentages of subjects showing adverse events after administration of drugs in differ...

Relative Reporting Ratios (RRR) of the adverse event “rash” for a given list of drugs.

Ruwen Böhm (3123936)
Leocadie von Hehn (3165036)
Thomas Herdegen (329707)
Hans-Joachim Klein (3165042)
Oliver Bruhn (3165033)
Holger Petri (3165045)
Jan Höcker (3165039)

June 2016

A RRR value of 1 indicates the normal background noise, e.g., associations by chance. An increase...

Relative risk of adverse events in randomized controlled trials with bee venom therapy and saline.

Jeong Hwan Park (742550)
Bo Kyung Yim (742551)
Jun-Hwan Lee (742552)
Sanghun Lee (742553)
Tae-Hun Kim (62458)

May 2015

Relative risk of adverse events in randomized controlled trials with bee venom therapy and saline...

Risk patterns in drug safety study using relative times by accelerated failure time models when proportional hazards assumption is questionable : An illustrative case study of cancer risk of patients on glucose-lowering therapies

Ng, Edmond S W
Klungel, Olaf H.
Groenwold, Rolf H H
Van Staa, Tjeerd Pieter

September 2015

Observational drug safety studies may be susceptible to confounding or protopathic bias. This bias m...

Comparison of the rates of antibiotic changes after each testA.

Kayoko Hayakawa (420483)
Kazuhisa Mezaki (547392)
Masao Kobayakawa (775279)
Kei Yamamoto (4170022)
Yoshikazu Mutoh (4268503)
Motoyuki Tsuboi (4268506)
Takehiro Hasimoto (4268500)
Maki Nagamatsu (547391)
Satoshi Kutsuna (3308052)
Nozomi Takeshita (3308049)
Yuichi Katanami (4170031)
Masahiro Ishikane (580253)
Norio Ohmagari (295944)

July 2017

Comparison of the rates of antibiotic changes after each test<a href="http://www.plosone.org/arti...

Incidence of adverse drug reactions.*

Monique Wasunna (157135)
Simon Njenga (3119955)
Manica Balasegaram (156987)
Neal Alexander (18417)
Raymond Omollo (156992)
Tansy Edwards (122527)
Thomas P. C. Dorlo (321337)
Brima Musa (157009)
Mohammed Hassan Sharaf Ali (3119958)
Mohammed Yasein Elamin (3119946)
George Kirigi (157066)
Rashid Juma (463480)
Anke E. Kip (3119949)
Gerard J. Schoone (244545)
Asrat Hailu (59005)
Joseph Olobo (156982)
Sally Ellis (157129)
Robert Kimutai (157106)
Susan Wells (3119952)
Eltahir Awad Gasim Khalil (3119940)
Nathalie Strub Wourgaft (3119943)
Fabiana Alves (217602)
Ahmed Musa (156973)

September 2016

Incidence of adverse drug reactions.<a href="http://www.plosntds.org/article/info:doi/10.137...

Distribution of outcomes in case of exposure.

Laurent Coudeville (112236)
Annelies Van Rie (36715)
Denis Getsios (60905)
J. Jaime Caro (371754)
Pascal Crépey (371756)
Van Hung Nguyen (60909)

February 2013

Distribution of outcomes in case of contact with an infectious person according to immunological ...

Incidence of patient complications.

ZheFeng Quan (738491)
Ming Tian (382196)
Ping Chi (738492)
Xin Li (51274)
HaiLi He (738493)
Chao Luo (343569)

May 2015

* Values presented as n (%)<a href="http://www.plosone.org/article/info:doi/10.1371/j...

Relation between the probability of disease and the threshold probabilities for testing and treatment (adopted from [3]).

Athanasios Tsalatsanis (354144)
Iztok Hozo (68993)
Ambuj Kumar (302537)
Benjamin Djulbegovic (68992)

August 2015

Relation between the probability of disease and the threshold probabilities for testing and treat...

Adverse effects during treatmenta.

Emily K. Tarleton (4175953)
Benjamin Littenberg (65282)
Charles D. MacLean (4175950)
Amanda G. Kennedy (4175947)
Christopher Daley (1779979)

June 2017

Adverse effects during treatment<a href="http://www.plosone.org/article/info:doi/10.1371/journal....

Individual risk for ARB acquisition.

Jonatan Almagor (5215994)
Elizabeth Temkin (5215991)
Itzhak Benenson (328126)
Noga Fallach (5215988)
Yehuda Carmeli (224072)

May 2018

Probability of ARB-H and ARB-L acquisition during a 6-day hospital stay for patients treated and ...

Quantitative methods to support drug benefit-risk assessment

Caster, Ola

January 2014

Joint evaluation of drugs’ beneficial and adverse effects is required in many situations, in particu...

Odds ratio and 95% confidence intervals for the rate of hazardous prescribing at each quarter interval compared to preintervention for the composite outcomes.

Sarah Rodgers (2646067)
Amelia C. Taylor (14129688)
Stephen A. Roberts (8494242)
Thomas Allen (1342170)
Darren M. Ashcroft (7359257)
James Barrett (3861232)
Matthew J. Boyd (14129691)
Rachel A. Elliott (8569593)
Kamlesh Khunti (171607)
Aziz Sheikh (18504)
Despina Laparidou (4440106)
Aloysius Niroshan Siriwardena (7399064)
Anthony J. Avery (5900345)

November 2022

Odds ratio and 95% confidence intervals for the rate of hazardous prescribing at each quarter interv...

Summary of all treatment-related adverse events (safety population).

Chaoying Hu (713788)
Jingying Jia (713789)
Kelly Dong (713790)
Linda Luo (713791)
Kai Wu (221862)
Rashmi Mehta (713792)
Jack Peng (713793)
Yan Ren (149348)
Annette Gross (713794)
Hui Yu (27723)

March 2015

*n numbers represent the number of subjects experiencing an event, which may be different to the ...

Study on the Increased Probability of Detecting Adverse Drug Reactions Based on Bayes’ Theorem: Evaluation of the Usefulness of Information on the Onset Timing of Adverse Drug Reactions

大島, 新司
延壽寺, 恭子
根岸, 彰生
秋元, 勇人
大原, 厚祐
冲田, 光良
沼尻, 幸彦
井上, 直子
大嶋, 繁
寺尾, 哲
小林, 大介

September 2017

In order to avoid adverse drug reactions (ADRs), pharmacists are reconstructing ADR-related informat...

Number and percentages of subjects showing adverse events after administration of drugs in different treatment arms.

Shantanu Kumar Kar (704077)
Bhagirathi Dwibedi (704078)
Anna Salomi Kerketa (704079)
Antaryami Maharana (704080)
Sudanshu S Panda (704081)
Prafulla Chandra Mohanty (704082)
John Horton (218580)
Cherubala P Ramachandran (704083)

March 2015

Number and percentages of subjects showing adverse events after administration of drugs in differ...

Relative Reporting Ratios (RRR) of the adverse event “rash” for a given list of drugs.

Ruwen Böhm (3123936)
Leocadie von Hehn (3165036)
Thomas Herdegen (329707)
Hans-Joachim Klein (3165042)
Oliver Bruhn (3165033)
Holger Petri (3165045)
Jan Höcker (3165039)

June 2016

A RRR value of 1 indicates the normal background noise, e.g., associations by chance. An increase...

Relative risk of adverse events in randomized controlled trials with bee venom therapy and saline.

Jeong Hwan Park (742550)
Bo Kyung Yim (742551)
Jun-Hwan Lee (742552)
Sanghun Lee (742553)
Tae-Hun Kim (62458)

May 2015

Relative risk of adverse events in randomized controlled trials with bee venom therapy and saline...

Risk patterns in drug safety study using relative times by accelerated failure time models when proportional hazards assumption is questionable : An illustrative case study of cancer risk of patients on glucose-lowering therapies

Ng, Edmond S W
Klungel, Olaf H.
Groenwold, Rolf H H
Van Staa, Tjeerd Pieter

September 2015

Observational drug safety studies may be susceptible to confounding or protopathic bias. This bias m...

Comparison of the rates of antibiotic changes after each testA.

Kayoko Hayakawa (420483)
Kazuhisa Mezaki (547392)
Masao Kobayakawa (775279)
Kei Yamamoto (4170022)
Yoshikazu Mutoh (4268503)
Motoyuki Tsuboi (4268506)
Takehiro Hasimoto (4268500)
Maki Nagamatsu (547391)
Satoshi Kutsuna (3308052)
Nozomi Takeshita (3308049)
Yuichi Katanami (4170031)
Masahiro Ishikane (580253)
Norio Ohmagari (295944)

July 2017

Comparison of the rates of antibiotic changes after each test<a href="http://www.plosone.org/arti...

Probability and ranges of a medication adverse event.<sup>a</sup><sup>,</sup> <sup>b</sup>

Abstract

Extracted data

Probability and ranges of a medication adverse event.<sup>a</sup><sup>,</sup> <sup>b</sup>

Abstract

Extracted data

Related items

Related items